GI
IRWD icon

GAMMA Investing’s Ironwood Pharmaceuticals IRWD Stock Holding History

GAMMA Investing’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10K Sell
2,382
-29
-1% -$112 ﹤0.01% 3201
2026
Q1 		$8.46K Sell
2,411
-51
-2% -$209 ﹤0.01% 3159
2025
Q4 		$8.3K Buy
+2,462
New +$6.39K ﹤0.01% 3057
2024
Q4 		– Sell
-6,170
Closed -$25.4K – 3805
2024
Q3 		$25.4K Sell
6,170
-4,356
-41% -$23.4K ﹤0.01% 1958
2024
Q2 		$68.6K Buy
10,526
+8,156
+344% +$57.7K 0.01% 986
2024
Q1 		$20.6K Buy
2,370
+945
+66% +$11.5K ﹤0.01% 1631
2023
Q4 		$20.2K Buy
+1,425
New +$14.1K 0.01% 1500

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
RFG
Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's IRWD Position: Q2 2026 in Review

GAMMA Investing reduced its Ironwood Pharmaceuticals (IRWD) stake by 1.2% in Q2 2026, selling an estimated $112 and leaving 2,382 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

GAMMA Investing first reported a position in IRWD in Q4 2023 and has held it in 7 quarters since. The position peaked at $68.6K in Q2 2024. 14 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • GAMMA Investing held 2,382 shares of Ironwood Pharmaceuticals worth $10K as of Q2 2026.
  • GAMMA Investing sold 29 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $112.
  • Ironwood Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3201 holding.
  • GAMMA Investing first reported a position in Ironwood Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
  • GAMMA Investing's Ironwood Pharmaceuticals position peaked at $68.6K in Q2 2024.
  • 14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.